Rimkus; Katrin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rimkus; Katrin.The latest application filed is for "method for the production of a medicament containing tadalafil".

Company Profile

0.8.27

Rimkus; Katrin - Munich DE
RIMKUS; Katrin - Pullach DE
Rimkus; Katrin - Iserlohn DE
Rimkus; Katrin - Munchen N/A DE
Rimkus; Katrin - Muenchen DE
Rimkus; Katrin - North Rhine-Westphalia DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For The Production Of A Medicament Containing Tadalafil App 20160101103 - Alles; Rainer ; et al.	2016-04-14
Method For Producing Dosage Form Comprising Odanacatib App 20160081971 - RIMKUS; Katrin ; et al.	2016-03-24
Method for the production of a medicament containing tadalafil Grant 9,238,007 - Alles , et al. January 19, 2	2016-01-19
Oral Dosage Forms For Modified Release Comprising Ruxolitinib App 20150246043 - Stefan; Ralph ; et al.	2015-09-03
Desfesoterodine in the form of a tartaric acid salt Grant 9,085,507 - Fischer , et al. July 21, 2	2015-07-21
Oral dosage form of deferasirox Grant 8,703,203 - Paetz , et al. April 22, 2	2014-04-22
Solid Composition Containing The Ingredient Rasagiline App 20130345310 - Rimkus; Katrin ; et al.	2013-12-26
Pharmaceutical composition comprising N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5[[[2-(methylsulfonyl)e- thyl]amino]methyl]-quinazolinamine Grant 8,586,091 - Rimkus , et al. November 19, 2	2013-11-19
Pharmaceutical Compositions Comprising 5-chloro-n-(-methyl)-2-thiophencarboxamid App 20130281457 - Rimkus; Katrin ; et al.	2013-10-24
Oral Dosage Form Of Deferasirox App 20130142871 - Paetz; Jana ; et al.	2013-06-06
Method Of Preparing An Oral Dosage Form Comprising Fingolimod App 20130095177 - Paetz; Jana ; et al.	2013-04-18
Ivabradine-containing Pharmaceutical Composition App 20130084335 - Meergans; Dominique ; et al.	2013-04-04
Composition Comprising Fesoterodine And Fiber App 20120258171 - Stumm; Daniela ; et al.	2012-10-11
Pharmaceutical Composition Having The Active Substances Metformin And Sitagliptin Or Vildagliptin App 20120202820 - Rimkus; Katrin ; et al.	2012-08-09
Co-precipitate Comprising A Phosphodiesterase-5 Inhibitor (pde-5-inhibitor) And A Pharmaceutically Compatible Carrier, Production And Use Thereof App 20120189694 - Rimkus; Katrin ; et al.	2012-07-26
Desfesoterodine In The Form Of A Tartaric Acid Salt App 20120128773 - Fischer; Dirk ; et al.	2012-05-24
Dry Processing Of Retigabine App 20120122973 - Paetz; Jana ; et al.	2012-05-17
Retigabine Tablets, Preferably Having Modified Release App 20120058183 - Brueck; Sandra ; et al.	2012-03-08
Solid Retigabine In Non-crystalline Form App 20120053238 - Paetz; Jana ; et al.	2012-03-01
Intermediate And Oral Administrative Formats Containing Lenalidomide App 20120046315 - Rimkus; Katrin ; et al.	2012-02-23
Pharmaceutical Composition Comprising N-[3-chloro-4-[(3-fluorophenyl)methoxy] Phenyl]-6-[5[[[2-(methylsulfonyl) Ethyl]amino]methyl]-2-furyl]-4- Quinazolinamine App 20120015965 - Rimkus; Katrin ; et al.	2012-01-19
Solid Composition Containing The Ingredient Rasagiline App 20110313050 - Rimkus; Katrin ; et al.	2011-12-22
Pharmaceutical Composition Comprising N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5[[[2-(methylsulfonyl)e- Thyl]amino]methyl]-2-furyl]-4- Quinazolinamine App 20110305762 - Rimkus; Katrin ; et al.	2011-12-15
Pharmaceutical Compositions Comprising 5-chloro-n-(-methyl)-2-thiophencarboxamid App 20110300214 - Rimkus; Katrin ; et al.	2011-12-08
Pharmaceutical Formulation For Lowering Pulmonary Blood Pressure App 20110189243 - Rimkus; Katrin ; et al.	2011-08-04
Pharmaceutical Compositions With Modified Release Properties Comprising 5-chloro-n-(-methyl)-2-thiophencarboxamid App 20110189279 - Rimkus; Katrin ; et al.	2011-08-04
Method For The Production Of A Medicament Containing Tadalafil App 20100179159 - Alles; Rainer ; et al.	2010-07-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.